Evidence map›Paper›PMID 30769819›Full record

ReviewMolecules (Basel, Switzerland)2019

Bioactivity Profile of the Diterpene Isosteviol and its Derivatives.

Asad Ullah, Sidra Munir, Yahia Mabkhot, Syed Lal Badshah

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 66 citations in OpenAlex.

  1. Neuroprotective effects ofFrontiers in molecular biosciences · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Synthesis and Biological Application of Isosteviol-Based 1,3-Aminoalcohols.International journal of molecular sciences · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Asad UllahDepartment of Chemistry, Islamia College University Peshawar, Peshawar 25120, Pakistan. asad_icp@yahoo.com.ORCID 0000-0002-0142-8565
Sidra MunirDepartment of Chemistry, Islamia College University Peshawar, Peshawar 25120, Pakistan. saries92@gmail.com.
Yahia MabkhotDepartment of Pharmacy, King Khalid University, Abha 62529, Saudi Arabia. ygaber@kku.edu.sa.ORCID 0000-0002-9762-0323
Syed Lal BadshahDepartment of Chemistry, Islamia College University Peshawar, Peshawar 25120, Pakistan. shahbiochemist@gmail.com.ORCID 0000-0002-0229-1425
Islamia College University · PKKing Khalid University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Steviosides, rebaudiosides and their analogues constitute a major class of naturally occurring biologically active diterpene compounds. The wide spectrum of pharmacological activity of this group of compounds has developed an interest among medicinal chemists to synthesize, purify, and analyze more selective and potent isosteviol derivatives. It has potential biological applications and improves the field of medicinal chemistry by designing novel drugs with the ability to cope against resistance developing diseases. The outstanding advancement in the design and synthesis of isosteviol and its derivative has proved its effectiveness and importance in the field of medicinal chemical research. The present review is an effort to integrate recently developed novel drugs syntheses from isosteviol and potentially active pharmacological importance of the isosteviol derivatives covering the recent advances.

Indexed as

Chemistry, PharmaceuticalDiterpenesDiterpenes, KauraneDrug DesignHumansStructure-Activity RelationshipDiterpenesDiterpenes, Kauraneisosteviolantitumorditerpenoidsisosteviolnatural productsstevioside

Identifiers

PMID30769819
PMCPMC6412665
OpenAlexW2912311437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.